Literature DB >> 20156925

Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria.

Vinesh Narayan1, Peter M Haddad.   

Abstract

We critically appraised all published reports of hypomania and mania following antidepressant termination. To increase reliability and validity we devised diagnostic criteria for an antidepressant discontinuation or withdrawal 'manic state' based primarily on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition substance withdrawal criteria. A systematic literature review identified 24 reports meeting our criteria. Mean age was 39 years (range 18-74), men and women were approximately equally represented, and more cases involved people with unipolar (n = 19) than bipolar disorder (n = 4). The median duration of preceding antidepressant treatment was 12 weeks (range 4 weeks-12 years). All major antidepressant classes were involved (tricyclic antidepressants = 13; selective serotonin reuptake inhibitors = 5; monoamine oxidase inhibitors = 3; selective serotonin-norepinephrine reuptake inhibitors = 2; miscellaneous = 1). More cases followed abrupt antidepressant withdrawal (n = 11) than a tapered withdrawal (n = 6). Six cases appeared to meet the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition for a manic episode, with two cases requiring inpatient admission. Of the 24 cases, nine resolved spontaneously without treatment (median duration = 25.5 days), six responded to antimanic drugs, four resolved following antidepressant reinstatement, and treatment was unclear in five cases. We conclude that antidepressant discontinuation hypomania/mania is a valid syndrome. It should be added to the differential diagnosis of hypomania/mania. The clinical implications and possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156925     DOI: 10.1177/0269881109359094

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  8 in total

Review 1.  Antidepressants and psychostimulants in pediatric populations: is there an association with mania?

Authors:  Michelle Goldsmith; Manpreet Singh; Kiki Chang
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

2.  Bipolar disorder, comorbid anxiety disorders, gynecomastia and dental pain: case analysis with literature review.

Authors:  Kenneth R Kaufman; Ronke Babalola; Miriam Campeas; Melissa Coluccio
Journal:  BJPsych Open       Date:  2018-04-26

3.  Antidepressant withdrawal - the tide is finally turning.

Authors:  Michael P Hengartner; James Davies; John Read
Journal:  Epidemiol Psychiatr Sci       Date:  2019-08-22       Impact factor: 6.892

4.  Vortioxetine Induced Hypomania: A Case Presentation and Review of the Literature.

Authors:  Ece Buyuksandalyaci Tunc; Serhat Tunc
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

5.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

6.  Withdrawal Symptoms Following Discontinuation of Vortioxetine-Retrospective Chart Review.

Authors:  Marcin Siwek; Adrian Andrzej Chrobak; Aleksandra Gorostowicz; Anna Julia Krupa; Dominika Dudek
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11

7.  Mirtazapine withdrawal-induced mania.

Authors:  Jitendra Kumar Verma; Satyakam Mohapatra
Journal:  J Pharmacol Pharmacother       Date:  2015 Oct-Dec

8.  Autopsy-proven Mirtazapine Withdrawal-induced Mania/Hypomania Associated with Sudden Death.

Authors:  Rena Pombo; Etta Johnson; Alejandra Gamboa; Bennet Omalu
Journal:  J Pharmacol Pharmacother       Date:  2017 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.